Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo
about
Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.Trichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells in vitro and in vivoSignificance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas.Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis.
P2860
Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Lovastatin overcomes gefitinib ...... statuses in vitro and in vivo
@ast
Lovastatin overcomes gefitinib ...... statuses in vitro and in vivo
@en
type
label
Lovastatin overcomes gefitinib ...... statuses in vitro and in vivo
@ast
Lovastatin overcomes gefitinib ...... statuses in vitro and in vivo
@en
prefLabel
Lovastatin overcomes gefitinib ...... statuses in vitro and in vivo
@ast
Lovastatin overcomes gefitinib ...... statuses in vitro and in vivo
@en
P2093
P2860
P356
P1433
P1476
Lovastatin overcomes gefitinib ...... statuses in vitro and in vivo
@en
P2093
Chien-Chung Chen
Hung-Yun Lin
Jinghan Wang
Keqiang Zhang
Sheng-Huei Yang
Vincent H S Chang
Xiaoqing Jiang
Yun-Ru Liu
P2860
P304
23857-23873
P356
10.18632/ONCOTARGET.4408
P407
P577
2015-06-23T00:00:00Z